Antibiotic types | Total (n = 117) | Pneumonia-related bacteremia (n = 45) | Nonpneumonia-related bacteremia (n = 72) | Χ2 | P |
---|---|---|---|---|---|
Levofloxacin Ceftazidime Imipenem Piperacillin/ tazobactam Ciprofloxacin Minocycline Tobramycin Meropenem Cefepime Ticarcillin/ clavulanic acid Cefopetazone/ sulbactam Doxycycline Compound Xinnuomin Amikacin Tigecycline Colistin CR-AB MDR-AB | 50.4%(59/117) 60.6%(71/117) 58.9%(69/117) 67%(67/100) 60.75%(65/107) 16.48%(15/91) 54.2%(58/107) 78.89%(62/90) 55.5%(65/117) 70%(63/90) 52.94%(54/102) 57.14%(52/91) 48.7%(57/117) 17.39%(4/23) 5.88%(6/102) 3.37%(3/91) 58.97%(69/117) 61.53%(72/117) | 77.7%(35/45) 82.2%(37/45) 80%(36/45) 83.72%(36/43) 86.05%(37/43) 26.83%(11/41) 76.74%(33/43) 77.7%(35/45) 75.5%(34/45) 85.36%(35/41) 69.76%(30/43) 73.17%(30/41) 60%(27/45) 40%(2/5) 6.98%(3/43) 2.44%(1/41) 80%(36/45) 84.44%(38/45) | 33.3%(24/72) 47.2%(34/72) 45.8%(33/72) 54.38%(31/57) 43.75%(28/64) 8%(4/50) 39.07%(25/64) 56%(28/50) 43%(31/72) 57.14%(28/49) 40.68%(24/59) 44%(22/50) 41.6%(30/72) 11.11%(2/18) 5.08%(3/59) 4.17%(2/48) 45.83%(33/72) 47.22%(34/72) | 21.88 14.21 8.03 9.54 19.29 5.8 15.29 8.72 11.84 8.46 3.44 7.82 3.72 2.27 0.15 0.20 13.36 16.21 | 0 0 0.006 0.03 0 0.023 0 0.005 0.001 0.004 0.005 0.006 0.06 0.19 0.69 1 0 0 |